Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
NCT01843634
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
ODSH
Sponsor
Jazz Pharmaceuticals